Can microbiota research change our understanding of neurodegenerative diseases?

References

• 1 Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285), 59–65 (2010).
  Medline CASGoogle Scholar
• 2 Baquero F, Nombela C. The microbiome as a human organ. Clin. Microbiol. Infect. 18(Suppl. 4), 2–4 (2012).
  Medline CASGoogle Scholar
• 3 Lederberg J, McCray AT. ‘Ome SweetOmics – a genealogical treasury of words. Scientist 15(7), 8 (2001).
  Google Scholar
• 4 Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486(7402), 207–214 (2012).
  MedlineGoogle Scholar
• 5 Maheshwari P, Eslick GD. Bacterial infection and Alzheimer's disease: a meta-analysis. J. Alzheimers Dis. 43(3), 957–966 (2015).
  MedlineGoogle Scholar
• 6 Agostini S, Clerici M, Mancuso R. How plausible is a link between HSV-1 infection and Alzheimer's disease? Expert Rev. Anti Infect. Ther. 12(3), 275–278 (2014).
  Medline CASGoogle Scholar
• 7 Alonso R, Pisa D, Marina AI, Morato E, Rabano A, Carrasco L. Fungal infection in patients with Alzheimer's disease. J. Alzheimers Dis. 41(1), 301–311 (2014).
  Medline CASGoogle Scholar
• 8 Alonso R, Pisa D, Marina AI et al. Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis. Int. J. Biol. Sci. 11(5), 546–558 (2015).
  Medline CASGoogle Scholar
• 9 Dobbs SM, Dobbs RJ, Weller C, Charlett A. Link between Helicobacter pylori infection and idiopathic Parkinsonism. Med. Hypotheses 55(2), 93–98 (2000).
  Medline CASGoogle Scholar
• 10 Banack SA, Caller TA, Stommel EW. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Toxins (Basel) 2(12), 2837–2850 (2010).
  Medline CASGoogle Scholar
• 11 Lim SL, Rodriguez-Ortiz CJ, Kitazawa M. Infection, systemic inflammation, and Alzheimer's disease. Microbes Infect. 17(8), 549–556 (2015).
  Medline CASGoogle Scholar
• 12 Bu XL, Wang X, Xiang Y et al. The association between infectious burden and Parkinson's disease: a case–control study. Parkinsonism Relat. Disord. 21(8), 877–881 (2015).
  MedlineGoogle Scholar
• 13 Bravo JA, Forsythe P, Chew MV et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl Acad. Sci. USA 108(38), 16050–16055 (2011).
  Medline CASGoogle Scholar
• 14 Bercik P, Denou E, Collins J et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141(2), 599–609, 609.e1–3 (2011).
  Medline CASGoogle Scholar
• 15 Berer K, Mues M, Koutrolos M et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479(7374), 538–541 (2011).
  Medline CASGoogle Scholar
• 16 Miyake S, Kim S, Suda W et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS ONE 10(9), e0137429 (2015).
  MedlineGoogle Scholar
• 17 Yin J, Liao SX, He Y et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J. Am. Heart Assoc. 4(11), e002699 (2015).
  MedlineGoogle Scholar
• 18 Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33(6), 599–614 (2007).
  Medline CASGoogle Scholar
• 19 Fasano A, Bove F, Gabrielli M et al. The role of small intestinal bacterial overgrowth in Parkinson's disease. Mov. Disord. 28(9), 1241–1249 (2013).
  Medline CASGoogle Scholar
• 20 Forsyth CB, Shannon KM, Kordower JH et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS ONE 6(12), e28032 (2011).
  Medline CASGoogle Scholar
• 21 Scheperjans F, Aho V, Pereira PA et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 30(3), 350–358 (2015).
  MedlineGoogle Scholar
• 22 Keshavarzian A, Green SJ, Engen PA et al. Colonic bacterial composition in Parkinson's disease. Mov. Disord. 30(10), 1351–1360 (2015).
  Medline CASGoogle Scholar
• 23 Hasegawa S, Goto S, Tsuji H et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease. PLoS ONE 10(11), e0142164 (2015).
  MedlineGoogle Scholar
• 24 Goldman SM, Kamel F, Ross GW et al. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov. Disord. 29(9), 1171–1180 (2014).
  Medline CASGoogle Scholar
• 25 Lema Tome CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P. Inflammation and alpha-synuclein's prion-like behavior in Parkinson's disease-is there a link? Mol. Neurobiol. 47(2), 561–574 (2013).
  Medline CASGoogle Scholar
• 26 Friedland RP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J. Alzheimers Dis. 45(2), 349–362 (2015).
  Medline CASGoogle Scholar
• 27 Hill JM, Lukiw WJ. Microbial-generated amyloids and Alzheimer's disease (AD). Front. Aging Neurosci. 7, 9 (2015).
  MedlineGoogle Scholar
• 28 Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson's disease – a role for gut microbiota? J. Parkinsons Dis. 5(2), 255–262 (2015).
  MedlineGoogle Scholar
• 29 Kamer AR, Craig RG, Pirraglia E et al. TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J. Neuroimmunol. 216(1), 92–97 (2009).
  Medline CASGoogle Scholar
• 30 Noble JM, Scarmeas N, Celenti RS et al. Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease. PLoS ONE 9(12), e114959 (2014).
  MedlineGoogle Scholar
• 31 Cockburn AF, Dehlin JM, Ngan T et al. High throughput DNA sequencing to detect differences in the subgingival plaque microbiome in elderly subjects with and without dementia. Investig. Genet. 3(1), 19 (2012).
  Medline CASGoogle Scholar
• 32 Harach T, Marungruang N, Dutilleul N et al. Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota. arXiv:1509.02273v2 [q-bio.MN] (2015).
  Google Scholar
• 33 Wu S, Yi J, Zhang YG, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 3(4), e12356 (2015).
  MedlineGoogle Scholar
• 34 van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368(5), 407–415 (2013).
  Medline CASGoogle Scholar